Fulcrum Therapeutics/$FULC
About Fulcrum Therapeutics
Ticker
Industry
Employees
FULC Metrics
$219M
-
-$0.29
2.11
-
Price and volume
Market cap
$219M
Beta
2.11
52-week high
$13.70
52-week low
$2.86
Average daily volume
985K
Financial strength
Current ratio
18.436
Quick ratio
18.09
Long term debt to equity
2.725
Total debt to equity
3.554
Management effectiveness
Return on assets (TTM)
-6.36%
Return on equity (TTM)
-6.99%
Valuation
Price to revenue (TTM)
3.119
Price to book
0.85
Price to tangible book (TTM)
0.85
Price to free cash flow (TTM)
-28.86
Growth
Revenue change (TTM)
2,987.86%
Earnings per share change (TTM)
-82.83%
3-year revenue growth (CAGR)
64.01%
3-year earnings per share growth (CAGR)
-50.24%
What the Analysts think about FULC
Analyst Ratings
FULC Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
FULC Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
FULC News
FAQs
What’s the current market cap for Fulcrum Therapeutics stock?
What is the P/E ratio for Fulcrum Therapeutics stock?
Does Fulcrum Therapeutics stock pay dividends?
No, Fulcrum Therapeutics (FULC) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Fulcrum Therapeutics dividend payment date?
Fulcrum Therapeutics (FULC) stock does not pay dividends to its shareholders.
What is the beta indicator for Fulcrum Therapeutics?
Fulcrum Therapeutics (FULC) has a beta rating of 2.11. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.